These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21082951)

  • 1. Hepatosplenic T-cell lymphoma and TNF-α inhibitors.
    Pozadzides JV; Pro B
    Expert Rev Hematol; 2009 Dec; 2(6):611-4. PubMed ID: 21082951
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic transplantation for hepatosplenic alphabeta T-cell lymphoma.
    Mansour MR; Dogan A; Morris EC; Khwaja A; Linch DC; Mackinnon S; Peggs KS
    Bone Marrow Transplant; 2005 May; 35(9):931-4. PubMed ID: 15778731
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma.
    Chanan-Khan A; Islam T; Alam A; Miller KC; Gibbs J; Barcos M; Czuczman MS; Paplham P; Hahn T; McCarthy P
    Leuk Lymphoma; 2004 Aug; 45(8):1673-5. PubMed ID: 15370223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
    Thai A; Prindiville T
    J Crohns Colitis; 2010 Nov; 4(5):511-22. PubMed ID: 21122554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab use and hepatosplenic T cell lymphoma: questions to be asked and lessons learned.
    Rosh JR; Oliva-Hemker M
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):165-7. PubMed ID: 17255825
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatosplenic gamma-delta T-cell lymphoma.
    Ferreri AJ; Govi S; Pileri SA
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.
    Ochenrider MG; Patterson DJ; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):144-8. PubMed ID: 20371449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.
    Ooi J; Iseki T; Adachi D; Yamashita T; Tomonari A; Tojo A; Tani K; Asano S
    Haematologica; 2001 Oct; 86(10):E25. PubMed ID: 11602432
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children.
    Lo Nigro L; Munda S; Poli A; Licciardello M; D'Amico S; Di Cataldo A
    Pediatr Blood Cancer; 2007 Oct; 49(5):763. PubMed ID: 17120239
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
    Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
    Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma.
    He S; Roberts A; Ritchie D; Grigg A
    Leuk Lymphoma; 2007 Jul; 48(7):1448-50. PubMed ID: 17613781
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review.
    Yabe M; Medeiros LJ; Daneshbod Y; Davanlou M; Bueso-Ramos CE; Moran EJ; Young KH; Miranda RN
    Ann Diagn Pathol; 2017 Feb; 26():16-22. PubMed ID: 28038706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of effective use of alemtuzumab in a male patient with T-cell lymphoma].
    Sokolov AH; Parovichnikova EN; Isaev VG; Ustinova EN; Shavlokhov VS; Atopkov VA; Model SV; Tsyba NN; Kaplanskaia IB; Kliasova GA; Aleksanian MZh; Vishnevskaia ES; Togonidze DK; Mirzoian EE; Savchenko VG
    Ter Arkh; 2004; 76(12):73-5. PubMed ID: 15724932
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastroenterology: Hepatosplenic T cell lymphoma associated with schistosomiasis.
    Azevedo P; Pedrosa MS; Resende V
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1333. PubMed ID: 26211690
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at risk.
    Parakkal D; Sifuentes H; Semer R; Ehrenpreis ED
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1150-6. PubMed ID: 21941193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.
    Mackey AC; Green L; Liang LC; Dinndorf P; Avigan M
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):265-7. PubMed ID: 17255842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.
    Drini M; Prichard PJ; Brown GJ; Macrae FA
    Med J Aust; 2008 Oct; 189(8):464-5. PubMed ID: 18928444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma.
    Rashidi A; Cashen AF
    Blood Cancer J; 2015 Jun; 5(6):e318. PubMed ID: 26047388
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma.
    Sumi M; Takeda W; Kaiume H; Kirihara T; Kurihara T; Sato K; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Kobayashi H
    Leuk Lymphoma; 2015 Apr; 56(4):1140-2. PubMed ID: 25065703
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatosplenic T cell lymphoma in inflammatory bowel disease.
    Shale M; Kanfer E; Panaccione R; Ghosh S
    Gut; 2008 Dec; 57(12):1639-41. PubMed ID: 18667489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.